Explore News
-
Why New Ovarian Cancer Treatment Matters
New treatment provides improved quality of life for patients
-
Retatrutide Yields 28% Weight Loss in 80 Weeks
Eli Lilly’s experimental drug retatrutide led to unprecedented weight reduction in trial participants, signaling a…
-
New Drug Candidate Offers Hope for Chronic Itch Sufferers
A newly developed compound shows promise in targeting the stubborn nerve signals behind chronic itch,…
-
New Drug Cuts Breast Density by 15% in Clinical Trial
A clinical trial of (Z)-endoxifen shows significant reduction in mammographic breast density—a known cancer risk…
